Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Make sure to share details about any other medications you're taking or any existing health conditions with your doctor to prevent possible interactions or complications
Presented for research literature review only Andreozzi GM (2009)
Clin Diagn Lab Immunol (1998) 5(4):4307
In July 2023, Gilead partnered with the Clinton Health Access Initiative (CHAI) and the Penta ID network, a scientific organization dedicated to child health research, to accelerate the development, regulatory approval and commercialization of a dispersible, fixed-dose combination treatment for the treatment of children with HIV who weigh at least 3 kg and live in low- and middle-income countries (LMICs)
